Thereapeutic Recommendantion for Children With a Hodgkin Lymphoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age0-18
SponsorFrench Africa Pediatric Oncology Group
About this trial
The GFAOP propose a simple and reproducible staging according to clinical, biological and radiological data.
Develop standardized but different therapeutic recommendations based on the availability or lack of radiation therapy in the pilot unites who will adapt these recommendations.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
suffering from "classical" Hodgkin's disease according to the WHO classification.
with no history of hematological malignancies or constitutional or acquired immune deficiencies
Disqualifiers
Over 18 years of age at diagnosis
A history of hematological malignancies or a history of constitutional or a history of acquired immune deficiencies
Trial population
All children arriving in one of the participating units : under 18 years of age at diagnosis and suffering from "classical" Hodgkin's disease according to the WHO classification.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Observational
Other interventionDescriptive data will be collected to evaluation compliance with the protocol and to evaluate outcome
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Patient status
Dead or Alive
Time frame
24 months2
Drugs
The evaluation of the number of children who remain untreated because of lack of acess to chemotherapy
Time frame
24 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
French Africa Pediatric Oncology Group
Lead sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Collaborator
Source ClinicalTrials.gov